Presentation
Presence of KIR2DS1 receptor in donors of allogeneic hematopoietic transplantation due to myeloid malignancies improves overall survival in recipients with HLA-C2 antigens
Author
Presentation
Male specific survival advantage of HLA-DRB1*04 for lymphoid malignancies following allogeneic haematopoietic stem cell transplantation
Speaker